|
1
|
Laplane L, Duluc D, Larmonier N, Pradeu T
and Bikfalvi A: The multiple layers of the tumor environment.
Trends Cancer. 4:802–809. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elia I and Haigis MC: Metabolites and the
tumour microenvironment: From cellular mechanisms to systemic
metabolism. Nat Metab. 3:21–32. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Q, Liu G, Liu S, Su H, Wang Y, Li J
and Luo C: Remodeling the tumor microenvironment with emerging
nanotherapeutics. Trends Pharmacol Sci. 39:59–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lazar I, Clement E, Attane C, Muller C and
Nieto L: A new role for extracellular vesicles: How small vesicles
can feed tumors' big appetite. J Lipid Res. 59:1793–1804. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu Q, Li B, Li Z, Li J and Sun S and Sun
S: Cancer-associated adipocytes: Key players in breast cancer
progression. J Hematol Oncol. 12:952019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dirat B, Bochet L, Dabek M, Daviaud D,
Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S,
et al: Cancer-associated adipocytes exhibit an activated phenotype
and contribute to breast cancer invasion. Cancer Res. 71:2455–2465.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vaupel H, Schmidberger A and Mayer A: The
Warburg effect: Essential part of metabolic reprogramming and
central contributor to cancer progression. Int J Radiat Biol.
95:912–919. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoxhaj G and Manning BD: The PI3K-AKT
network at the interface of oncogenic signalling and cancer
metabolism. Nat Rev Cancer. 20:74–88. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nieman KM, Romero IL, Van Houten B and
Lengyel E: Adipose tissue and adipocytes support tumorigenesis and
metastasis. Biochim Biophys Acta. 1831:1533–1541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iyengar P, Combs TP, Shah SJ, Gouon-Evans
V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C,
Lisanti MP, et al: Adipocyte-secreted factors synergistically
promote mammary tumorigenesis through induction of anti-apoptotic
transcriptional programs and proto-oncogene stabilization.
Oncogene. 22:6408–6423. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park J, Morley TS, Kim M, Clegg DJ and
Scherer PE: Obesity and cancer-mechanisms underlying tumour
progression and recurrence. Nat Rev Endocrinol. 10:455–465. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Donohoe CL, Lysaght J, O'sullivan J and
Reynolds JV: Emerging concepts linking obesity with the hallmarks
of cancer. Trends Endocrinol Metab. 28:46–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kahn CR, Wang G and Lee KY: Altered
adipose tissue and adipocyte function in the pathogenesis of
metabolic syndrome. J Clin Invest. 129:3990–4000. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scheja L and Heeren J: The endocrine
function of adipose tissues in health and cardiometabolic disease.
Nat Rev Endocrinol. 15:507–524. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fujisaki K, Fujimoto H, Sangai T,
Nagashima T, Sakakibara M, Shiina N, Kuroda M, Aoyagi Y and
Miyazaki M: Cancer-mediated adipose reversion promotes cancer cell
migration via IL-6 and MCP-1. Breast Cancer Res Treat. 150:255–263.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao C, Wu M, Zeng N, Xiong M, Hu W, Lv W,
Yi Y, Zhang Q and Wu Y: Cancer-associated adipocytes: Emerging
supporters in breast cancer. J Exp Clin Cancer Res. 39:1562020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi J, Cha YJ and Koo JS: Adipocyte
biology in breast cancer: From silent bystander to active
facilitator. Prog Lipid Res. 69:11–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rybinska I, Agresti R, Trapani A,
Tagliabue E and Triulzi T: Adipocytes in breast cancer, the thick
and the thin. Cells. 9:5602020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pérez-Escuredo J, Van Hée VF, Sboarina M,
Falces J, Payen VL, Pellerin L and Sonveaux P: Monocarboxylate
transporters in the brain and in cancer. Biochim Biophys Acta.
1863:2481–2497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang E, Wang X, Gong Z, Yu M, Wu H and
Zhang D: Exosome-mediated metabolic reprogramming: The emerging
role in tumor microenvironment remodeling and its influence on
cancer progression. Signal Transduct Target Ther. 5:2422020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiong X, Wen YA, Fairchild R, Zaytseva YY,
Weiss HL, Evers BM and Gao T: Upregulation of CPT1A is essential
for the tumor-promoting effect of adipocytes in colon cancer. Cell
Death Dis. 11:7362020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schlaepfer IR, Rider L, Rodrigues LU,
Gijón MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glodé LM,
Eckel RH and Cramer SD: Lipid catabolism via CPT1 as a therapeutic
target for prostate cancer. Mol Cancer Ther. 13:2361–2371. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tabuso M, Homer-Vanniasinkam S, Adya R and
Arasaradnam RP: Role of tissue microenvironment resident adipocytes
in colon cancer. World J Gastroenterol. 23:5829–5835. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ko JH, Um JY, Lee SG, Yang WM, Sethi G and
Ahn KS: Conditioned media from adipocytes promote proliferation,
migration, and invasion in melanoma and colorectal cancer cells. J
Cell Physiol. 234:18249–18261. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fontana L, Eagon JC, Trujillo ME, Scherer
PE and Klein S: Visceral fat adipokine secretion is associated with
systemic inflammation in obese humans. Diabetes. 56:1010–1013.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Catalán V, Gómez-Ambrosi J, Rodríguez A,
Ramírez B, Silva C, Rotellar F, Hernández-Lizoain JL, Baixauli J,
Valentí V, Pardo F, et al: Up-regulation of the novel
proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and
osteopontin as well as angiogenic-related factors in visceral
adipose tissue of patients with colon cancer. J Nutr Biochem.
22:634–641. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peterson JE, Zurakowski D, Italiano JE Jr,
Michel LV, Connors S, Oenick M, D'Amato RJ, Klement GL and Folkman
J: VEGF, PF4 and PDGF are elevated in platelets of colorectal
cancer patients. Angiogenesis. 15:265–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lumeng CN, Deyoung SM, Bodzin JL and
Saltiel AR: Increased inflammatory properties of adipose tissue
macrophages recruited during diet-induced obesity. Diabetes.
56:16–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu H, Barnes GT, Yang Q, Tan G, Yang D,
Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA and Chen H:
Chronic inflammation in fat plays a crucial role in the development
of obesity-related insulin resistance. J Clin Invest.
112:1821–1830. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Harvey AE, Lashinger LM and Hursting SD:
The growing challenge of obesity and cancer: An inflammatory issue.
Ann N Y Acad Sci. 1229:45–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wagner M, Bjerkvig R, Wiig H,
Melero-Martin JM, Lin RZ, Klagsbrun M and Dudley AC: Inflamed
tumor-associated adipose tissue is a depot for macrophages that
stimulate tumor growth and angiogenesis. Angiogenesis. 15:481–495.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amor S, Iglesias-de la Cruz MC, Ferrero E,
García-Villar O, Barrios V, Fernandez N, Monge L, García-Villalón
AL and Granado M: Peritumoral adipose tissue as a source of
inflammatory and angiogenic factors in colorectal cancer. Int J
Colorectal Dis. 31:365–375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ye P, Xi Y, Huang Z and Xu P: Linking
obesity with colorectal cancer: Epidemiology and mechanistic
insights. Cancers (Basel). 12:14082020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lapeire L, Hendrix A, Lambein K, Van
Bockstal M, Braems G, Van Den Broecke R, Limame R, Mestdagh P,
Vandesompele J, Vanhove C, et al: Cancer-associated adipose tissue
promotes breast cancer progression by paracrine oncostatin M and
Jak/STAT3 signaling. Cancer Res. 74:6806–6819. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
D'Esposito V, Liguoro D, Ambrosio MR,
Collina F, Cantile M, Spinelli R, Raciti GA, Miele C, Valentino R,
Campiglia P, et al: Adipose microenvironment promotes triple
negative breast cancer cell invasiveness and dissemination by
producing CCL5. Oncotarget. 7:24495–24509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
De Palma M, Biziato D and Petrova TV:
Microenvironmental regulation of tumour angiogenesis. Nat Rev
Cancer. 17:457–474. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang YY, Attané C, Milhas D, Dirat B,
Dauvillier S, Guerard A, Gilhodes J, Lazar I, Alet N, Laurent V, et
al: Mammary adipocytes stimulate breast cancer invasion through
metabolic remodeling of tumor cells. JCI Insight. 2:e874892017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Attane C, Milhas D, Hoy AJ and Muller C:
Metabolic remodeling induced by adipocytes: A new Achille heels in
invasive breast cancer? Curr Med Chem. 27:3984–4001. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bussard KM, Mutkus L, Stumpf K,
Gomez-Manzano C and Marini FC: Tumor associated stromal cells as
key contributors to the tumor microenvironment. Breast Cancer Res.
18:842016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lengyel E: Ovarian cancer development and
metastasis. Am J Pathol. 177:1053–1064. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
John B, Naczki C, Patel C, Ghoneum A,
Qasem S, Salih Z and Said N: Regulation of the bi-directional
cross-talk between ovarian cancer cells and adipocytes by SPARC.
Oncogene. 38:4366–4383. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mukherjee A, Chiang CY, Daifotis HA,
Nieman KM, Fahrmann JF, Lastra RR, Romero IL, Fiehn O and Lengyel
E: Adipocyte-induced FABP4 expression in ovarian cancer cells
promotes metastasis and mediates carboplatin resistance. Cancer
Res. 80:1748–1761. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sun C, Li X, Guo E, Li N, Zhou B, Lu H,
Huang J, Xia M, Shan W, Wang B, et al: MCP-1/CCR-2 axis in
adipocytes and cancer cell respectively facilitates ovarian cancer
peritoneal metastasis. Oncogene. 39:1681–1695. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nieman KM, Kenny HA, Penicka CV, Ladanyi
A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB,
Hotamisligil GS, et al: Adipocytes promote ovarian cancer
metastasis and provide energy for rapid tumor growth. Nat Med.
17:1498–1503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Coburn CT, Knapp FF Jr, Febbraio M, Beets
AL, Silverstein RL and Abumrad NA: Defective uptake and utilization
of long chain fatty acids in muscle and adipose tissues of CD36
knockout mice. J Biol Chem. 275:32523–32529. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Au Yeung CL, Co NN, Tsuruga T, Yeung TL,
Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, et al: Exosomal
transfer of stroma-derived miR21 confers paclitaxel resistance in
ovarian cancer cells through targeting APAF1. Nat Commun.
7:111502016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Renehan AG, Tyson M, Egger M, Heller RF
and Zwahlen M: Body-mass index and incidence of cancer: A
systematic review and meta-analysis of prospective observational
studies. Lancet. 371:569–578. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sun X, Wang M, Wang M, Yu X, Guo J, Sun T,
Li X, Yao L, Dong H and Xu Y: Metabolic reprogramming in
triple-negative breast cancer. Front Oncol. 10:4282020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Santander AM, Lopez-Ocejo O, Casas O,
Agostini T, Sanchez L, Lamas-Basulto E, Carrio R, Cleary MP,
Gonzalez-Perez RR and Torroella-Kouri M: Paracrine interactions
between adipocytes and tumor cells recruit and modify macrophages
to the mammary tumor microenvironment: The role of obesity and
inflammation in breast adipose tissue. Cancers (Basel). 7:143–178.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Corn KC, Windham MA and Rafat M: Lipids in
the tumor microenvironment: From cancer progression to treatment.
Prog Lipid Res. 80:1010552020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pallegar NK and Christian SL: Adipocytes
in the tumour microenvironment. Adv Exp Med Biol. 1234:1–13. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dias AS, Almeida CR, Helguero LA and
Duarte IF: Metabolic crosstalk in the breast cancer
microenvironment. Eur J Cancer. 121:154–171. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Balaban S, Shearer RF, Lee LS, van
Geldermalsen M, Schreuder M, Shtein HC, Cairns R, Thomas KC,
Fazakerley DJ, Grewal T, et al: Adipocyte lipolysis links obesity
to breast cancer growth: Adipocyte-derived fatty acids drive breast
cancer cell proliferation and migration. Cancer Metab. 5:12017.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang D, Li Y, Xing L, Tan Y, Sun J, Zeng
B, Xiang T, Tan J, Ren G and Wang Y: Utilization of
adipocyte-derived lipids and enhanced intracellular trafficking of
fatty acids contribute to breast cancer progression. Cell Commun
Signal. 16:322018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zaoui M, Morel M, Ferrand N, Fellahi S,
Bastard JP, Lamazière A, Larsen AK, Béréziat V, Atlan M and Sabbah
M: Breast-associated adipocytes secretome induce fatty acid uptake
and invasiveness in breast cancer cells via CD36 independently of
body mass index, menopausal status and mammary density. Cancers
(Basel). 11:20122019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ladanyi A, Mukherjee A, Kenny HA, Johnson
A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag
A, et al: Adipocyte-induced CD36 expression drives ovarian cancer
progression and metastasis. Oncogene. 37:2285–2301. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang M, Di Martino JS, Bowman RL,
Campbell NR, Baksh SC, Simon-Vermot T, Kim IS, Haldeman P, Mondal
C, Yong-Gonzales V, et al: Adipocyte-derived lipids mediate
melanoma progression via FATP proteins. Cancer Discov. 8:1006–1025.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lopes-Coelho F, Andre S, Felix A and Serpa
J: Breast cancer metabolic cross-talk: Fibroblasts are hubs and
breast cancer cells are gatherers of lipids. Mol Cell Endocrinol.
462:93–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang T, Fahrmann JF, Lee H, Li YJ,
Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, et al:
JAK/STAT3-regulated fatty acid β-oxidation is critical for breast
cancer stem cell self-renewal and chemoresistance. Cell Metab.
27:136–150.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhang C, Yue C, Herrmann A, Song J,
Egelston C, Wang T, Zhang Z, Li W, Lee H, Aftabizadeh M, et al:
STAT3 activation-induced fatty acid oxidation in CD8+ T
effector cells is critical for obesity-promoted breast tumor
growth. Cell Metab. 31:148–161.e5. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Cawthorn WP, Scheller EL, Learman BS,
Parlee SD, Simon BR, Mori H, Ning X, Bree AJ, Schell B, Broome DT,
et al: Bone marrow adipose tissue is an endocrine organ that
contributes to increased circulating adiponectin during caloric
restriction. Cell Metab. 20:368–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ye H, Adane B, Khan N, Sullivan T,
Minhajuddin M, Gasparetto M, Stevens B, Pei S, Balys M, Ashton JM,
et al: Leukemic stem cells evade chemotherapy by metabolic
adaptation to an adipose tissue niche. Cell Stem Cell. 19:23–37.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Auciello FR, Bulusu V, Oon C, Tait-Mulder
J, Berry M, Bhattacharyya S, Tumanov S, Allen-Petersen BL, Link J,
Kendsersky ND, et al: A stromal lysolipid-autotaxin signaling axis
promotes pancreatic tumor progression. Cancer Discov. 9:617–627.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Benesch MG, Tang X, Maeda T, Ohhata A,
Zhao YY, Kok BP, Dewald J, Hitt M, Curtis JM, McMullen TP and
Brindley DN: Inhibition of autotaxin delays breast tumor growth and
lung metastasis in mice. FASEB J. 28:2655–2666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yang L, Yu X and Yang Y: Autotaxin
upregulated by STAT3 activation contributes to invasion in
pancreatic neuroendocrine neoplasms. Endocr Connect. 7:1299–1307.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Azare J, Doane A, Leslie K, Chang Q,
Berishaj M, Nnoli J, Mark K, Al-Ahmadie H, Gerald W, Hassimi M, et
al: Stat3 mediates expression of autotaxin in breast cancer. PLoS
One. 6:e278512011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Schmid R, Wolf K, Robering JW, Strauß S,
Strissel PL, Strick R, Rübner M, Fasching PA, Horch RE, Kremer AE,
et al: ADSCs and adipocytes are the main producers in the
autotaxin-lysophosphatidic acid axis of breast cancer and healthy
mammary tissue in vitro. BMC Cancer. 18:12732018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Corbet C and Feron O: Emerging roles of
lipid metabolism in cancer progression. Curr Opin Clin Nutr Metab
Care. 20:254–260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Pascual G, Avgustinova A, Mejetta S,
Martín M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A,
Hueto JA, et al: Targeting metastasis-initiating cells through the
fatty acid receptor CD36. Nature. 541:41–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wculek SK and Malanchi I: Neutrophils
support lung colonization of metastasis-initiating breast cancer
cells. Nature. 528:413–417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Poltavets V, Kochetkova M, Pitson SM and
Samuel MS: The role of the extracellular matrix and its molecular
and cellular regulators in cancer cell plasticity. Front Oncol.
8:4312018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Bacac M and Stamenkovic I: Metastatic
cancer cell. Annu Rev Pathol. 3:221–247. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ribeiro RJ, Monteiro CP, Cunha VF, Azevedo
AS, Oliveira MJ, Monteiro R, Fraga AM, Príncipe P, Lobato C, Lobo
F, et al: Tumor cell-educated periprostatic adipose tissue acquires
an aggressive cancer-promoting secretory profile. Cell Physiol
Biochem. 29:233–240. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Lee SG, Kim JS, Kim HJ, Schlaepfer DD, Kim
IS and Nam JO: Endothelial angiogenic activity and adipose
angiogenesis is controlled by extracellular matrix protein TGFBI.
Sci Rep. 11:96442021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Campo-Verde-Arbocco F, López-Laur JD,
Romeo LR, Giorlando N, Bruna FA, Contador DE, López-Fontana G,
Santiano FE, Sasso CV, Zyla LE, et al: Human renal adipose tissue
induces the invasion and progression of renal cell carcinoma.
Oncotarget. 8:94223–94234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Iyengar P, Espina V, Williams TW, Lin Y,
Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, et al:
Adipocyte-derived collagen VI affects early mammary tumor
progression in vivo, demonstrating a critical interaction in the
tumor/stroma microenvironment. J Clin Invest. 115:1163–1176. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Bochet L, Meulle A, Imbert S, Salles B,
Valet P and Muller C: Cancer-associated adipocytes promotes breast
tumor radioresistance. Biochem Biophys Res Commun. 411:102–106.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Tennant DA, Durán RV and Gottlieb E:
Targeting metabolic transformation for cancer therapy. Nat Rev
Cancer. 10:267–277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ueda S, Saeki T, Osaki A, Yamane T and
Kuji I: Bevacizumab induces acute hypoxia and cancer progression in
patients with refractory breast cancer: Multimodal functional
imaging and multiplex cytokine analysis. Clin Cancer Res.
23:5769–5778. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Levitsky A, Brismar K, Hafström I,
Hambardzumyan K, Lourdudoss C, van Vollenhoven RF and Saevarsdottir
S: Obesity is a strong predictor of worse clinical outcomes and
treatment responses in early rheumatoid arthritis: Results from the
SWEFOT trial. RMD Open. 3:e0004582017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Castillo JJ, Mulkey F, Geyer S, Kolitz JE,
Blum W, Powell BL, George SL, Larson RA and Stone RM: Relationship
between obesity and clinical outcome in adults with acute myeloid
leukemia: A pooled analysis from four CALGB (alliance) clinical
trials. Am J Hematol. 91:199–204. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Laurent V, Guérard A, Mazerolles C, Le
Gonidec S, Toulet A, Nieto L, Zaidi F, Majed B, Garandeau D,
Socrier Y, et al: Periprostatic adipocytes act as a driving force
for prostate cancer progression in obesity. Nat Commun.
7:102302016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Osman MA and Hennessy BT: Obesity
correlation with metastases development and response to first-line
metastatic chemotherapy in breast cancer. Clin Med Insights Oncol.
9:105–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Engin A: Obesity-associated breast cancer:
Analysis of risk factors. Adv Exp Med Biol. 960:571–606. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Cao Y: Tumor angiogenesis and molecular
targets for therapy. Front Biosci (Landmark Ed). 14:3962–3973.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Iwamoto H, Abe M, Yang Y, Cui D, Seki T,
Nakamura M, Hosaka K, Lim S, Wu J, He X, et al: Cancer lipid
metabolism confers antiangiogenic drug resistance. Cell Metab.
28:104–117.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Hedlund EM, Yang X, Zhang Y, Yang Y,
Shibuya M, Zhong W, Sun B, Liu Y, Hosaka K and Cao Y: Tumor
cell-derived placental growth factor sensitizes antiangiogenic and
antitumor effects of anti-VEGF drugs. Proc Natl Acad Sci USA.
110:654–659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Honek J, Seki T, Iwamoto H, Fischer C, Li
J, Lim S, Samani NJ, Zang J and Cao Y: Modulation of age-related
insulin sensitivity by VEGF-dependent vascular plasticity in
adipose tissues. Proc Natl Acad Sci USA. 111:14906–14911. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yang Y, Zhang Y, Iwamoto H, Hosaka K, Seki
T, Andersson P, Lim S, Fischer C, Nakamura M, Abe M, et al:
Discontinuation of anti-VEGF cancer therapy promotes metastasis
through a liver revascularization mechanism. Nat Commun.
7:126802016. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Levine AJ and Puzio-Kuter AM: The control
of the metabolic switch in cancers by oncogenes and tumor
suppressor genes. Science. 330:1340–1344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Park JH, Vithayathil S, Kumar S, Sung PL,
Dobrolecki LE, Putluri V, Bhat VB, Bhowmik SK, Gupta V, Arora K, et
al: Fatty acid oxidation-driven src links mitochondrial energy
reprogramming and oncogenic properties in triple-negative breast
cancer. Cell Rep. 14:2154–2165. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Trédan O, Lacroix-Triki M, Guiu S,
Mouret-Reynier MA, Barrière J, Bidard FC, Braccini AL, Mir O,
Villanueva C and Barthélémy P: Angiogenesis and tumor
microenvironment: Bevacizumab in the breast cancer model. Target
Oncol. 10:189–198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Incio J, Ligibel JA, McManus DT, Suboj P,
Jung K, Kawaguchi K, Pinter M, Babykutty S, Chin SM, Vardam TD, et
al: Obesity promotes resistance to anti-VEGF therapy in breast
cancer by up-regulating IL-6 and potentially FGF-2. Sci Transl Med.
10:eaag09452018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Casanovas O, Hicklin DJ, Bergers G and
Hanahan D: Drug resistance by evasion of antiangiogenic targeting
of VEGF signaling in late-stage pancreatic islet tumors. Cancer
Cell. 8:299–309. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Dimou NL, Papadimitriou N, Mariosa D,
Johansson M, Brennan P, Peters U, Chanock SJ, Purdue M, Bishop DT,
Gago-Dominquez M, et al: Circulating adipokine concentrations and
risk of five obesity-related cancers: A mendelian randomization
study. Int J Cancer. 148:1625–1636. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Cha YJ, Kim ES and Koo JS:
Tumor-associated macrophages and crown-like structures in adipose
tissue in breast cancer. Breast Cancer Res Treat. 170:15–25. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Lee JO, Kim N, Lee HJ, Lee YW, Kim SJ,
Park SH and Kim HS: Resistin, a fat-derived secretory factor,
promotes metastasis of MDA-MB-231 human breast cancer cells through
ERM activation. Sci Rep. 6:189232016. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Xiong Y, Russell DL, McDonald LT, Cowart
LA and LaRue AC: Hematopoietic stem cell-derived adipocytes promote
tumor growth and cancer cell migration. Int J Cancer Res Mol Mech.
3:102017.PubMed/NCBI
|
|
106
|
Wang C, Gao C, Meng K, Qiao H and Wang Y:
Human adipocytes stimulate invasion of breast cancer MCF-7 cells by
secreting IGFBP-2. PLoS One. 10:e01193482015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Sánchez-Jiménez F, Pérez-Pérez A, de la
Cruz-Merino L and Sánchez-Margalet V: Obesity and breast cancer:
Role of leptin. Front Oncol. 9:5962019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ando S, Barone I, Giordano C, Bonofiglio D
and Catalano S: The multifaceted mechanism of leptin signaling
within tumor microenvironment in driving breast cancer growth and
progression. Front Oncol. 4:3402014.PubMed/NCBI
|
|
109
|
Gnerlich JL, Yao KA, Fitchev PS,
Goldschmidt RA, Bond MC, Cornwell M and Crawford SE: Peritumoral
expression of adipokines and fatty acids in breast cancer. Ann Surg
Oncol. 20 (Suppl 3):S731–S738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Okumura M, Yamamoto M, Sakuma H, Kojima T,
Maruyama T, Jamali M, Cooper DR and Yasuda K: Leptin and high
glucose stimulate cell proliferation in MCF-7 human breast cancer
cells: Reciprocal involvement of PKC-alpha and PPAR expression.
Biochim Biophys Acta. 1592:107–116. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Zhou W, Guo S and Gonzalez-Perez RR:
Leptin pro-angiogenic signature in breast cancer is linked to IL-1
signalling. Br J Cancer. 104:128–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Wei L, Li K, Pang X, Guo B, Su M, Huang Y,
Wang N, Ji F, Zhong C, Yang J, et al: Leptin promotes
epithelial-mesenchymal transition of breast cancer via the
upregulation of pyruvate kinase M2. J Exp Clin Cancer Res.
35:1662016. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Juárez-Cruz JC, Zuñiga-Eulogio MD,
Olea-Flores M, Castañeda-Saucedo E, Mendoza-Catalán MÁ,
Ortuño-Pineda C, Moreno-Godínez ME, Villegas-Comonfort S,
Padilla-Benavides T and Navarro-Tito N: Leptin induces cell
migration and invasion in a FAK-Src-dependent manner in breast
cancer cells. Endocr Connect. 8:1539–1552. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Endo H, Hosono K, Uchiyama T, Sakai E,
Sugiyama M, Takahashi H, Nakajima N, Wada K, Takeda K, Nakagama H
and Nakajima A: Leptin acts as a growth factor for colorectal
tumours at stages subsequent to tumour initiation in murine colon
carcinogenesis. Gut. 60:1363–1371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
He JY, Wei XH, Li SJ, Liu Y, Hu HL, Li ZZ,
Kuang XH, Wang L, Shi X, Yuan ST and Sun L: Adipocyte-derived IL-6
and leptin promote breast cancer metastasis via upregulation of
Lysyl Hydroxylase-2 expression. Cell Commun Signal. 16:1002018.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Li K, Wei L, Huang Y, Wu Y, Su M, Pang X,
Wang N, Ji F, Zhong C and Chen T: Leptin promotes breast cancer
cell migration and invasion via IL-18 expression and secretion. Int
J Oncol. 48:2479–2487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Maroni P: Leptin, adiponectin, and Sam68
in bone metastasis from breast cancer. Int J Mol Sci. 21:10512020.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Sultana R, Kataki AC, Borthakur BB,
Basumatary TK and Bose S: Imbalance in leptin-adiponectin levels
and leptin receptor expression as chief contributors to triple
negative breast cancer progression in Northeast India. Gene.
621:51–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Chung SJ, Nagaraju GP, Nagalingam A,
Muniraj N, Kuppusamy P, Walker A, Woo J, Győrffy B, Gabrielson E,
Saxena NK and Sharma D: ADIPOQ/adiponectin induces cytotoxic
autophagy in breast cancer cells through STK11/LKB1-mediated
activation of the AMPK-ULK1 axis. Autophagy. 13:1386–1403. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Wu Q, Li B and Sun S and Sun S: Unraveling
adipocytes and cancer links: Is there a role for senescence? Front
Cell Dev Biol. 8:2822020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Hardie DG: AMP-activated/SNF1 protein
kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell
Biol. 8:774–785. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Theriau CF, Sauvé OS, Beaudoin MS, Wright
DC and Connor MK: Proliferative endocrine effects of adipose tissue
from obese animals on MCF7 cells are ameliorated by resveratrol
supplementation. PLoS One. 12:e01838972017. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Tae CH, Kim SE, Jung SA, Joo YH, Shim KN,
Jung HK, Kim TH, Cho MS, Kim KH and Kim JS: Involvement of
adiponectin in early stage of colorectal carcinogenesis. BMC
Cancer. 14:8112014. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Li W, Saud SM, Young MR, Chen G and Hua B:
Targeting AMPK for cancer prevention and treatment. Oncotarget.
6:7365–7378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Park SY, Kim D and Kee SH:
Metformin-activated AMPK regulates β-catenin to reduce cell
proliferation in colon carcinoma RKO cells. Oncol Lett.
17:2695–2702. 2019.PubMed/NCBI
|
|
127
|
Rutherford C, Speirs C, Williams JJ, Ewart
MA, Mancini SJ, Hawley SA, Delles C, Viollet B, Costa-Pereira AP,
Baillie GS, et al: Phosphorylation of Janus kinase 1 (JAK1) by
AMP-activated protein kinase (AMPK) links energy sensing to
anti-inflammatory signaling. Sci Signal. 9:ra1092016. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Waldner MJ, Foersch S and Neurath MF:
Interleukin-6-a key regulator of colorectal cancer development. Int
J Biol Sci. 8:1248–1253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Semaan J, Pinon A, Rioux B, Hassan L,
Limami Y, Pouget C, Fagnère C, Sol V, Diab-Assaf M, Simon A and
Liagre B: Resistance to 3-HTMC-induced apoptosis through activation
of PI3K/Akt, MEK/ERK, and p38/COX-2/PGE2 pathways in
human HT-29 and HCT116 colorectal cancer cells. J Cell Biochem.
117:2875–2885. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Yoshimura T: The chemokine MCP-1 (CCL2) in
the host interaction with cancer: A foe or ally? Cell Mol Immunol.
15:335–345. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Bonapace L, Coissieux MM, Wyckoff J, Mertz
KD, Varga Z, Junt T and Bentires-Alj M: Cessation of CCL2
inhibition accelerates breast cancer metastasis by promoting
angiogenesis. Nature. 515:130–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Tsuyada A, Chow A, Wu J, Somlo G, Chu P,
Loera S, Luu T, Li AX, Wu X, Ye W, et al: CCL2 mediates cross-talk
between cancer cells and stromal fibroblasts that regulates breast
cancer stem cells. Cancer Res. 72:2768–2779. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Saji H, Koike M, Yamori T, Saji S, Seiki
M, Matsushima K and Toi M: Significant correlation of monocyte
chemoattractant protein-1 expression with neovascularization and
progression of breast carcinoma. Cancer. 92:1085–1091. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Dommel S and Blüher M: Does C-C motif
chemokine ligand 2 (CCL2) link obesity to a pro-inflammatory state?
Int J Mol Sci. 22:15002021. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Faria SS, Corrêa LH, Heyn GS, de Sant'Ana
LP, Almeida RDN and Magalhães KG: Obesity and breast cancer: The
role of crown-like structures in breast adipose tissue in tumor
progression, prognosis, and therapy. J Breast Cancer. 23:233–245.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Hsieh CC and Huang YS: Aspirin breaks the
crosstalk between 3T3-L1 adipocytes and 4T1 breast cancer cells by
regulating cytokine production. PLoS One. 11:e01471612016.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Kuziel G, Thompson V, D'Amato JV and
Arendt LM: Stromal CCL2 signaling promotes mammary tumor fibrosis
through recruitment of myeloid-lineage cells. Cancers (Basel).
12:20832020. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Kranjc MK, Novak M, Pestell RG and Lah TT:
Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme.
Radiol Oncol. 53:397–406. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Suárez-Nájera LE, Chanona-Pérez JJ,
Valdivia-Flores A, Marrero-Rodríguez D, Salcedo-Vargas M,
García-Ruiz DI and Castro-Reyes MA: Morphometric study of
adipocytes on breast cancer by means of photonic microscopy and
image analysis. Microsc Res Tech. 81:240–249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Zazo S, González-Alonso P, Martín-Aparicio
E, Chamizo C, Luque M, Sanz-Álvarez M, Mínguez P, Gómez-López G,
Cristóbal I, Caramés C, et al: Autocrine CCL5 effect mediates
trastuzumab resistance by ERK pathway activation in HER2-positive
breast cancer. Mol Cancer Ther. 19:1696–1707. 2020.PubMed/NCBI
|
|
141
|
Song X, Zhou X, Qin Y, Yang J, Wang Y, Sun
Z, Yu K, Zhang S and Liu S: Emodin inhibits epithelial-mesenchymal
transition and metastasis of triple negative breast cancer via
antagonism of CC-chemokine ligand 5 secreted from adipocytes. Int J
Mol Med. 42:579–588. 2018.PubMed/NCBI
|
|
142
|
Gao D, Rahbar R and Fish EN: CCL5
activation of CCR5 regulates cell metabolism to enhance
proliferation of breast cancer cells. Open Biol. 6:1601222016.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Sax MJ, Gasch C, Athota VR, Freeman R,
Rasighaemi P, Westcott DE, Day CJ, Nikolic I, Elsworth B, Wei M, et
al: Cancer cell CCL5 mediates bone marrow independent angiogenesis
in breast cancer. Oncotarget. 7:85437–85449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Velasco-Velazquez M and Pestell RG: The
CCL5/CCR5 axis promotes metastasis in basal breast cancer.
Oncoimmunology. 2:e236602013. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Velasco-Velázquez M, Jiao X, De La Fuente
M, Pestell TG, Ertel A, Lisanti MP and Pestell RG: CCR5 antagonist
blocks metastasis of basal breast cancer cells. Cancer Res.
72:3839–3850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Kim EJ, Kim YK, Kim S, Kim JE, Tian YD,
Doh EJ, Lee DH and Chung JH: Adipochemokines induced by ultraviolet
irradiation contribute to impaired fat metabolism in subcutaneous
fat cells. Br J Dermatol. 178:492–501. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Keophiphath M, Rouault C, Divoux A,
Clement K and Lacasa D: CCL5 promotes macrophage recruitment and
survival in human adipose tissue. Arterioscler Thromb Vasc Biol.
30:39–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Shao L, Feng B, Zhang Y, Zhou H, Ji W and
Min W: The role of adipose-derived inflammatory cytokines in type 1
diabetes. Adipocyte. 5:270–274. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Brett E, Sauter M, Timmins É, Azimzadeh O,
Rosemann M, Merl-Pham J, Hauck SM, Nelson PJ, Becker KF, Schunn I,
et al: Oncogenic linear collagen VI of invasive breast cancer is
induced by CCL5. J Clin Med. 9:9912020. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Guo Y, Xu F, Lu T, Duan Z and Zhang Z:
Interleukin-6 signaling pathway in targeted therapy for cancer.
Cancer Treat Rev. 38:904–910. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Kim HS, Jung M, Choi SK, Woo J, Piao YJ,
Hwang EH, Kim H, Kim SJ and Moon WK: IL-6-mediated cross-talk
between human preadipocytes and ductal carcinoma in situ in breast
cancer progression. J Exp Clin Cancer Res. 37:2002018. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Lee J, Hong BS, Ryu HS, Lee HB, Lee M,
Park IA, Kim J, Han W, Noh DY and Moon HG: Transition into
inflammatory cancer-associated adipocytes in breast cancer
microenvironment requires microRNA regulatory mechanism. PLoS One.
12:e01741262017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Bachelot T, Ray-Coquard I, Menetrier-Caux
C, Rastkha M, Duc A and Blay JY: Prognostic value of serum levels
of interleukin 6 and of serum and plasma levels of vascular
endothelial growth factor in hormone-refractory metastatic breast
cancer patients. Br J Cancer. 88:1721–1726. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Deng T, Lyon CJ, Bergin S, Caligiuri MA
and Hsueh WA: Obesity, inflammation, and cancer. Annu Rev Pathol.
11:421–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Liu S, Lee JS, Jie C, Park MH, Iwakura Y,
Patel Y, Soni M, Reisman D and Chen H: HER2 overexpression triggers
an IL1α proinflammatory circuit to drive tumorigenesis and promote
chemotherapy resistance. Cancer Res. 78:2040–2051. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Banerjee K and Resat H: Constitutive
activation of STAT3 in breast cancer cells: A review. Int J Cancer.
138:2570–2578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Nickel A, Blücher C, Kadri OA, Schwagarus
N, Müller S, Schaab M, Thiery J, Burkhardt R and Stadler SC:
Adipocytes induce distinct gene expression profiles in mammary
tumor cells and enhance inflammatory signaling in invasive breast
cancer cells. Sci Rep. 8:94822018. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Gyamfi J, Lee YH, Eom M and Choi J:
Interleukin-6/STAT3 signalling regulates adipocyte induced
epithelial-mesenchymal transition in breast cancer cells. Sci Rep.
8:88592018. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Jin K, Pandey NB and Popel AS:
Simultaneous blockade of IL-6 and CCL5 signaling for synergistic
inhibition of triple-negative breast cancer growth and metastasis.
Breast Cancer Res. 20:542018. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Guo C, Chen Y, Gao W, Chang A, Ye Y, Shen
W, Luo Y, Yang S, Sun P, Xiang R and Li N: Liposomal nanoparticles
carrying anti-IL6R antibody to the tumour microenvironment inhibit
metastasis in two molecular subtypes of breast cancer mouse models.
Theranostics. 7:775–788. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Gyamfi J, Lee YH, Min BS and Choi J:
Niclosamide reverses adipocyte induced epithelial-mesenchymal
transition in breast cancer cells via suppression of the
interleukin-6/STAT3 signalling axis. Sci Rep. 9:113362019.
View Article : Google Scholar : PubMed/NCBI
|
